Actos does have warnings for bladder cancer with use for extended periods of time. Actos lawyers are filing lawsuits for people who have developed bladder cancer as a part of a multi district litigation.
FDA Warnings For Actos and Bladder Cancer
FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer
Actos Bladder Cancer Safety Announcement
[6-15-2011] The U.S. Food and Drug Administration (FDA) is informing the public that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines.
Actos Bladder Cancer Lawsuit
Actos lawsuits are being filed on behalf of type II diabetics who developed bladder cancer from long-term use of the drug Actos. These lawsuits continue to move forward in a multidistrict litigation in U.S. District Court, Western District of Louisiana. More than 2,500 Actos bladder cancer lawsuits are currently pending in the Western District of Louisiana, where the first trials are scheduled to begin in January.
Actos Product Liability Litigation, MDL No. 2299
If you believe you, a loved one or someone you are a caregiver for has gotten bladder cancer and has been on Actos call and speak to an Actos lawyer today. There must be a confirmed diagnosis of bladder cancer to be added to the lawsuit.